HomeCompareTKAGY vs PFE

TKAGY vs PFE: Dividend Comparison 2026

TKAGY yields 3.73% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TKAGY wins by $126.3K in total portfolio value
10 years
TKAGY
TKAGY
● Live price
3.73%
Share price
$15.28
Annual div
$0.57
5Y div CAGR
43.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$177.3K
Annual income
$73,169.93
Full TKAGY calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — TKAGY vs PFE

📍 TKAGY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTKAGYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TKAGY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TKAGY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TKAGY
Annual income on $10K today (after 15% tax)
$317.18/yr
After 10yr DRIP, annual income (after tax)
$62,194.44/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, TKAGY beats the other by $39,065.48/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TKAGY + PFE for your $10,000?

TKAGY: 50%PFE: 50%
100% PFE50/50100% TKAGY
Portfolio after 10yr
$114.2K
Annual income
$50,190.24/yr
Blended yield
43.94%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

TKAGY
No analyst data
Altman Z
1.7
Piotroski
6/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TKAGY buys
0
PFE buys
0
No recent congressional trades found for TKAGY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTKAGYPFE
Forward yield3.73%6.20%
Annual dividend / share$0.57$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR43.5%13.2%
Portfolio after 10y$177.3K$51.1K
Annual income after 10y$73,169.93$27,210.54
Total dividends collected$145.3K$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TKAGY vs PFE ($10,000, DRIP)

YearTKAGY PortfolioTKAGY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,235$535.48$9,161$701.38+$2.1KTKAGY
2$12,829$806.87$8,610$859.79+$4.2KTKAGY
3$14,962$1,235.58$8,366$1,081.25+$6.6KTKAGY
4$17,942$1,932.65$8,483$1,405.66+$9.5KTKAGY
5$22,307$3,108.13$9,084$1,907.24+$13.2KTKAGY
6$29,050$5,182.25$10,418$2,732.78+$18.6KTKAGY
7$40,135$9,051.16$13,007$4,193.56+$27.1KTKAGY
8$59,715$16,770.47$18,010$7,005.87+$41.7KTKAGY
9$97,359$33,463.62$28,216$12,979.89+$69.1KTKAGY
10$177,344$73,169.93$51,081$27,210.54+$126.3KTKAGY

TKAGY vs PFE: Complete Analysis 2026

TKAGYStock

Telekom Austria AG, together with its subsidiaries, provides fixed-line and mobile communications solutions to individuals, commercial and non-commercial organizations, and other national and international carriers. The company offers fixed-line services, including access, Internet, fixed-to-mobile calls, international traffic, voice value-added, interconnection, call center, television, IPTV, and smart home services, as well as data and ICT solutions; and digital mobile communications services, such as text and multimedia messaging, m-commerce, information, and entertainment services. It also provides end-user terminal equipment; digital products; cloud and Internet of Things services; and mobile payment services. The company provides digital services and communications solutions to approximately 26 million customers. It has operations in Austria, Belarus, Bulgaria, Croatia, North Macedonia, Serbia, and Slovenia. The company is headquartered in Vienna, Austria. Telekom Austria AG is a subsidiary of América Móvil B.V.

Full TKAGY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this TKAGY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TKAGY vs SCHDTKAGY vs JEPITKAGY vs OTKAGY vs KOTKAGY vs MAINTKAGY vs JNJTKAGY vs MRKTKAGY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.